TARGETED MEDICAL PHARMA, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 20th, 2015 • Targeted Medical Pharma, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the “Purchase Agreement”) made as of this 13th day of January 2015, between Targeted Medical Pharma, Inc., a Delaware corporation with offices located at 2980 Beverly Glen Circle, Suite 301, Los Angeles, CA 90077 (the “Company”), and the undersigned (the “Purchaser”).
4% SENIOR SECURED CONVERTIBLE DEBENTURE DUE JANUARY 12, 2018Targeted Medical Pharma, Inc. • January 20th, 2015 • Pharmaceutical preparations • California
THIS 4% SENIOR SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 4% Senior Secured Convertible Debentures of Targeted Medical Pharma, Inc., a Delaware corporation, (the “Company”), having its principal place of business at 2980 Beverly Glen Circle, Suite 301, Los Angeles, CA 90077, designated as its 4% Senior Secured Convertible Debenture due January 12, 2018 (the “Debenture”).
SECURITY AGREEMENTSecurity Agreement • January 20th, 2015 • Targeted Medical Pharma, Inc. • Pharmaceutical preparations • California
This SECURITY AGREEMENT, dated as of January 13, 2015 (this “Agreement”), is among Targeted Medical Pharma, Inc., a Delaware corporation (the “Company”), Complete Claims Processing, Inc., a California corporation and wholly-owned subsidiary of the Company (the “Guarantor”), and the holder of the Company’s 4% Senior Secured Convertible Debenture due 3 years following its issuance, in the original aggregate principal amount of $650,000 (the “Debenture”) signatory hereto, its endorsees, transferees and assigns (collectively, the “Secured Parties”).
